IP Library Assignment 041689/0945
Patent Assignment
Reel/Frame 041689/0945

Grant of Security Interest in United States Patents

Recorded: 2017-02-13 Pages: 7
Assignor
ARCHER PHARMACEUTICALS, INC.
Executed: 2017-02-06
Assignee
AIA AMERICA, INC.
7835 PARALLEL PARKWAY, KANSAS CITY, KANSAS, 66112
Covered Properties (18)
Vasoactive Effects and Free Radical Generation by Beta-Amyloid Peptides
Patent: 6,140,309 →
Application: 08/615,593 →
Vasoactive Effects and Free Radical Generation by B-Amyloid Peptides
Patent: 6,011,019 →
Application: 08/747,457 →
Assay for Evaluating the Therapeutic Effectiveness of Agents in Reducing Alzheimer's Disease Pathology
Patent: 6,787,318 →
Application: 09/585,058 →
Inhibition of Angiogenesis by a-Beta Peptides
Patent: 7,589,168 →
Application: 10/217,584 →
Publication: US 2003/0077261
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
Application: 10/218,004 →
Publication: US 2003/0077667
Methods of identifying compounds useful in the inhibition of neurodegenerative disease
Application: 10/305,508 →
Publication: US 2003/0077573
CD45 Isoform Alteration in CD4+ T Cells as a Potential Diagnostic Marker in Alzheimer's Disease
Patent: 7,052,852 →
Application: 10/426,301 →
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
Application: 10/694,634 →
Publication: US 2004/0146949
Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors
Application: 10/780,905 →
Publication: US 2004/0229816
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
Application: 10/842,212 →
Publication: US 2005/0089939
Method for Reducing Amyloid Deposition, Amyloid Neurotoxicity and Microgliosis
Patent: 7,732,467 →
Application: 10/847,630 →
Publication: US 2005/0009885
Methods and Apparatus for Analyzing a Sample in the Presence of Interferents
Patent: 8,163,162 →
Application: 11/278,341 →
Publication: US 2007/0227912
Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
Application: 11/328,470 →
Publication: US 2006/0188938
Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
Application: 11/582,281 →
Publication: US 2007/0185130
Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
Application: 11/582,530 →
Publication: US 2007/0191409
Modulation of Angiogenesis by a-Beta Peptide Fragments
Patent: 8,067,372 →
Application: 11/598,299 →
Publication: US 2008/0031954
Compounds and Combinations Thereof for Inhibiting Beta-Amyloid Production and Methods of Use Thereof
Application: 11/774,357 →
Publication: US 2008/0058330
Method for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis with (-)-Nilvadipine Enantiomer
Patent: 8,236,346 →
Application: 12/245,354 →
Publication: US 2009/0092667
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 16, 2004
From: PARIS, DANIEL; MULLAN, MICHAEL J.
To: ROSKAMP RESEARCH LLC
Reel/Frame 015228/0123 →
Assignment of Assignor's Interest May 10, 2004
From: TAN, JUN; TOWN, TERRENCE; MULLAN, MICHAEL
To: THE UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 015321/0253 →
Assignment of Assignor's Interest Jul 16, 2004
From: PARIS, DANIEL; MULLAN, MICHAEL J.
To: ROSKAMP RESEARCH LLC
Reel/Frame 015566/0132 →
Assignment of Assignor's Interest Sep 14, 2004
From: MULLAN, MICHAEL J.; PARIS, DANIEL
To: ROSKAMP RESEARCH LLC
Reel/Frame 015125/0832 →
Assignment of Assignor's Interest Jan 28, 2005
From: THE UNIVERSITY OF SOUTH FLORIDA
To: ROSKAMP RESEARCH LLC
Reel/Frame 015621/0835 →
Assignment of Assignor's Interest Jun 9, 2006
From: CHATELIER, RONALD C.; HODGES, ALASTAIR MCINDOE; VERITY, BRUCE
To: LIFESCAN, INC.
Reel/Frame 017753/0001 →
Assignment of Assignor's Interest Jun 29, 2006
From: PARIS, DANIEL; MULLAN, MICHAEL J.; BAKSHI, PANCHAM
To: ROSKAMP RESEARCH LLC
Reel/Frame 017854/0114 →
Assignment of Assignor's Interest Jul 6, 2006
From: THE UNIVERSITY OF SOUTH FLORIDA
To: ROSKAMP RESEARCH, LLC
Reel/Frame 017884/0226 →
Assignment of Assignor's Interest Jul 6, 2006
From: PARIS, DANIEL; MULLAN, MICHAEL J.
To: ROSKAMP RESEARCH, LLC
Reel/Frame 017881/0199 →
Nunc Pro Tunc Assignment May 24, 2007
From: TAN, JUN; TOWN, TERRENCE C.; MULLAN, MICHAEL
To: THE UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 019339/0815 →
Assignment of Assignor's Interest Aug 10, 2007
From: PARIS, DANIEL; MULLAN, MICHAEL J.
To: ROSKAMP RESEARCH LLC
Reel/Frame 019677/0124 →
Assignment of Assignor's Interest Nov 7, 2008
From: PARIS, DANIEL; MULLAN, MICHAEL J.; BAKSHI, PANCHAM
To: ROSKAMP RESEARCH LLC
Reel/Frame 021803/0414 →
Assignment of Assignor's Interest Dec 4, 2008
From: MULLAN, MICHAEL J.; PARIS, DANIEL; IVEY, ROBERT A., III
To: ROSKAMP RESEARCH LLC
Reel/Frame 021944/0437 →
Assignment of Assignor's Interest Mar 8, 2010
From: ROSKAMP FOUNDATION IRREVOCABLE TRUST (D/B/A ROSKAMP INSTITUTE); ROSKAMP RESEARCH LLC; ARCHER PHARMACEUTICALS, INC.
To: ALZHEIMER'S INSTITUTE OF AMERICA, INC.
Reel/Frame 024046/0127 →
Assignment of Assignor's Interest Mar 9, 2010
From: ROSKAMP FOUNDATION IRREVOCABLE TRUST (D/B/A ROSKAMP INSTITUTE); ROSKAMP RESEARCH LLC; ARCHER PHARMACEUTICALS, INC.
To: ALZHEIMER'S INSTITUTE OF AMERICA, INC.
Reel/Frame 024049/0771 →
Assignment of Assignor's Interest Mar 9, 2010
From: ROSKAMP FOUNDATION IRREVOCABLE TRUST (D/B/A ROSKAMP INSTITUTE); ROSKAMP RESEARCH LLC; ARCHER PHARMACEUTICALS, INC.
To: ALZHEIMER'S INSTITUTE OF AMERICA, INC.
Reel/Frame 024049/0455 →
Assignment of Assignor's Interest Mar 9, 2010
From: ROSKAMP FOUNDATION IRREVOCABLE TRUST (D/B/A ROSKAMP INSTITUTE); ROSKAMP RESEARCH LLC; ARCHER PHARMACEUTICALS, INC.
To: ALZHEIMER'S INSTITUTE OF AMERICA, INC.
Reel/Frame 024049/0272 →
Assignment of Assignor's Interest Mar 9, 2010
From: ROSKAMP FOUNDATION IRREVOCABLE TRUST (D/B/A ROSKAMP INSTITUTE); ROSKAMP RESEARCH LLC
To: ALZHEIMER'S INSTITUTE OF AMERICA, INC.
Reel/Frame 024048/0473 →
Assignment of Assignor's Interest Apr 5, 2010
From: ROSKAMP FOUNDATION IRREVOCABLE TRUST (D/B/A ROSKAMP INSTITUTE); ROSKAMP RESEARCH LLC; ARCHER PHARMACEUTICALS, INC.
To: ALZHEIMER'S INSTITUTE OF AMERICA, INC.
Reel/Frame 024187/0071 →
Assignment of Assignor's Interest Aug 31, 2011
From: ROSKAMP FOUNDATION IRREVOCABLE TRUST D/B/A ROSKAMP INSTITUTE; ROSKAMP RESEARCH LLC; ARCHER PHARMACEUTICALS, INC.
To: ALZHEIMER'S INSTITUTE OF AMERICA, INC.
Reel/Frame 026839/0241 →
Assignment of Assignor's Interest Feb 13, 2017
From: AIA AMERICA, INC.
To: ARCHER PHARMACEUTICALS, INC.
Reel/Frame 041233/0541 →
Quitclaim Assignment Jun 12, 2018
From: AIA AMERICA, INC.
To: LIFESCAN, INC.
Reel/Frame 046347/0886 →
Quitclaim Assignment Jun 12, 2018
From: ARCHER PHARMACEUTICALS
To: LIFESCAN, INC.
Reel/Frame 046339/0144 →
Release of Security Interest Jun 12, 2018
From: AIA AMERICA, INC.
To: ARCHER PHARMACEUTICALS, INC.
Reel/Frame 046055/0704 →
Security Agreement Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →